Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Adicet Bio Inc
(NQ:
ACET
)
1.520
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Adicet Bio Inc
< Previous
1
2
3
Next >
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 29, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 01, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present at Upcoming Investor Conferences
June 21, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
June 06, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 03, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkin’s Lymphoma (NHL)
May 26, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present at Upcoming Investor Conferences
May 18, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates
May 12, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Presents Preclinical Data at the ISCT Annual Meeting Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies
May 05, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 04, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
April 27, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Receives FDA Fast Track Designation for Lead Candidate ADI-001
April 19, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in Upcoming Investor Conferences
April 07, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
March 15, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in Guggenheim 2022 Oncology Conference
February 02, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
September 13, 2021
From
Twist Bioscience Corporation and Adicet Bio
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.